Bruker (BRKR)
(Delayed Data from NSDQ)
$80.97 USD
+0.38 (0.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.94 -0.03 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for Bruker Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 488 | 646 | 1,168 | 732 | 685 |
Receivables | 492 | 473 | 417 | 335 | 362 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 968 | 800 | 710 | 692 | 577 |
Other Current Assets | 216 | 195 | 177 | 166 | 172 |
Total Current Assets | 2,164 | 2,113 | 2,472 | 1,925 | 1,796 |
Net Property & Equipment | 600 | 487 | 406 | 396 | 306 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 297 | 77 | 90 | 72 | 61 |
Intangibles | 913 | 729 | 551 | 550 | 526 |
Deposits & Other Assets | 184 | 155 | 71 | 40 | 17 |
Total Assets | 4,250 | 3,612 | 3,650 | 3,049 | 2,772 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 203 | 178 | 147 | 135 | 118 |
Current Portion Long-Term Debt | 121 | 19 | 112 | 2 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 878 | 717 | 679 | 655 | 527 |
Total Current Liabilities | 1,202 | 914 | 939 | 792 | 646 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 159 | 119 | 96 | 94 | 92 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,160 | 1,201 | 1,222 | 842 | 813 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 240 | 212 | 267 | 300 | 236 |
Minority Interest (Liabilities) | 19 | 6 | 0 | 0 | 21 |
Total Liabilities | 2,855 | 2,486 | 2,565 | 2,075 | 1,854 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 283 | 256 | 238 | 216 | 200 |
Retained Earnings | 2,324 | 1,926 | 1,660 | 1,407 | 1,275 |
Other Equity | 23 | 27 | 6 | 17 | -15 |
Treasury Stock | 1,237 | 1,085 | 820 | 667 | 544 |
Total Shareholder's Equity | 1,395 | 1,126 | 1,085 | 974 | 917 |
Total Liabilities & Shareholder's Equity | 4,250 | 3,612 | 3,650 | 3,049 | 2,772 |
Total Common Equity | 1,395 | 1,126 | 1,085 | 974 | 917 |
Shares Outstanding | 138.40 | 147.00 | 151.60 | 153.00 | 153.90 |
Book Value Per Share | 10.08 | 7.66 | 7.15 | 6.37 | 5.96 |
Fiscal Year End for Bruker Corporation falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 488 | 364 | 575 | 598 |
Receivables | NA | 492 | 485 | 451 | 472 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 968 | 916 | 915 | 859 |
Other Current Assets | NA | 216 | 264 | 243 | 205 |
Total Current Assets | NA | 2,164 | 2,029 | 2,183 | 2,133 |
Net Property & Equipment | NA | 600 | 527 | 523 | 511 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 297 | 0 | 0 | 0 |
Intangibles | NA | 913 | 853 | 858 | 826 |
Deposits & Other Assets | NA | 184 | 410 | 293 | 294 |
Total Assets | NA | 4,250 | 3,820 | 3,857 | 3,764 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 203 | 182 | 189 | 196 |
Current Portion Long-Term Debt | NA | 121 | 121 | 121 | 120 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 878 | 770 | 741 | 732 |
Total Current Liabilities | NA | 1,202 | 1,072 | 1,051 | 1,049 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 159 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 1,160 | 1,099 | 1,123 | 1,109 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 405 | 421 | 396 | |
Minority Interest (Liabilities) | NA | 19 | 17 | 12 | 12 |
Total Liabilities | NA | 2,855 | 2,593 | 2,606 | 2,565 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 2 | 2 | 2 | 2 |
Capital Surplus | NA | 283 | 0 | 0 | 0 |
Retained Earnings | NA | 2,324 | 0 | 0 | 0 |
Other Equity | NA | 23 | 2,412 | 2,356 | 2,304 |
Treasury Stock | NA | 1,237 | 1,187 | 1,107 | 1,107 |
Total Shareholder's Equity | NA | 1,395 | 1,227 | 1,251 | 1,199 |
Total Liabilities & Shareholder's Equity | NA | 4,250 | 3,820 | 3,857 | 3,764 |
Total Common Equity | 0 | 1,395 | 1,227 | 1,251 | 1,199 |
Shares Outstanding | 137.60 | 138.40 | 146.80 | 146.70 | 146.70 |
Book Value Per Share | 0.00 | 10.08 | 8.36 | 8.53 | 8.17 |